入院时致动脉粥样硬化性血脂异常与COVID-19住院患者不良结局相关
该回顾性研究分析2020年3-5月意大利罗马118例连续住院的COVID-19患者,发现入院时存在致动脉粥样硬化性血脂异常(高甘油三酯、低HDL)与住院期间危重症(死亡或需气管插管)显著相关(OR 2.53,95%CI 1.16-6.32,P=0.018)。危重症组致动脉粥样硬化性血脂异常比例更高(46% vs 24%,P=0.011),糖尿病比例也更高(37% vs 19%,P=0.026)。
要点
- 入院时致动脉粥样硬化性血脂异常与COVID-19住院危重症风险增加相关。
- 危重症患者更常见糖尿病、高甘油三酯和低HDL。
- 建议对COVID-19住院患者评估血脂谱。
核心结论
- 入院时检测到的致动脉粥样硬化性血脂异常可能与COVID-19住院期间危重症病程相关。
- 需要进一步研究阐明胰岛素抵抗及相关血脂异常在SARS-CoV-2发病机制中的假想作用。
- 应鼓励对COVID-19住院患者进行血脂谱评估。
研究设计与样本
- 回顾性分析2020年3月至5月意大利罗马连续住院的118例COVID-19患者的临床报告。
- 收集入院时临床特征、炎症标志物及糖脂代谢参数。
- 危重症定义为住院死亡或需气管插管。
- 采用逻辑回归分析检验关联。
主要发现
- 危重症COVID-19患者(n=43)显著年长于非危重症患者(n=75)。
- 危重症患者空腹血糖、甘油三酯、C反应蛋白、白介素-6、降钙素原和D-二聚体水平更高(所有P<0.01),HDL水平更低(P=0.003)。
- 致动脉粥样硬化性血脂异常在危重症患者中更常见(46% vs 24%,P=0.011),糖尿病也更常见(37% vs 19%,P=0.026)。
- 致动脉粥样硬化性血脂异常与死亡或插管显著相关(OR 2.53,95%CI 1.16-6.32,P=0.018)。
- 甘油三酯与部分炎症生物标志物显著相关(所有P<0.05),且在总体人群和致动脉粥样硬化性血脂异常亚组中与住院期间COVID-19不良结局相关。
临床怎么用
- 对COVID-19住院患者应鼓励评估血脂谱。
- 入院时发现致动脉粥样硬化性血脂异常可能提示需关注危重症风险。
局限性
- 回顾性分析,样本量118例,来自单中心。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Identifying metabolic factors associated with critical disease can help to improve management of patients hospitalized for coronavirus disease 2019 (COVID-19). High triglycerides and low HDL levels characterize the atherogenic dyslipidemia closely related to insulin resistance and diabetes. We examined associations of atherogenic dyslipidemia detected on admission with outcome of COVID-19 during hospitalization. RESEARCH DESIGN AND METHODS: We retrospectively analyzed clinical reports of 118 consecutive patients hospitalized for COVID-19 in Rome, Italy, between March and May 2020. Clinical characteristics, inflammation markers, and glucose and lipid metabolism parameters at admission were collected. Critical disease was defined as in-hospital death or need for endotracheal intubation. Associations were tested using logistic regression analysis. RESULTS: Patients with critical COVID-19 (n = 43) were significantly older than those with noncritical disease (n = 75) and presented higher levels of fasting glucose, triglycerides, C-reactive protein, interleukin-6, procalcitonin, and d-dimer (P < 0.01 for all), whereas HDL levels were lower (P = 0.003). Atherogenic dyslipidemia was more frequent in patients with critical COVID-19 (46 vs. 24%, P = 0.011), as well as diabetes (37 vs. 19%, P = 0.026), and significantly associated with death or intubation (odds ratio 2.53 [95% CI 1.16-6.32], P = 0.018). Triglycerides were significantly associated with selected inflammatory biomarkers (P < 0.05 for all) and poorer outcome of COVID-19 during hospitalization in both the overall population and the subgroup with atherogenic dyslipidemia. CONCLUSIONS: Atherogenic dyslipidemia detected on admission can be associated with critical in-hospital course of COVID-19. Further investigations are needed to elucidate the hypothetical role of insulin resistance and related lipid abnormalities in severe acute respiratory syndrome coronavirus 2 pathogenesis. Assessment of lipid profile should be encouraged in patients hospitalized for COVID-19.
引用
- Bellia A, Andreadi A, Giudice L, et al. Atherogenic Dyslipidemia on Admission Is Associated With Poorer Outcome in People With and Without Diabetes Hospitalized for COVID-19. Diabetes Care. 2021. PMID: 34253561. doi:10.2337/dc20-2838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。